Using MRI and radiomics to detect Brucella spondylitis
Radiomics Analysis Based on MRI to Detect Brucella Spondylitis
The Affiliated Hospital of Inner Mongolia Medical University · NCT06220500
This study is testing if advanced MRI techniques can help doctors better diagnose Brucella spondylitis in patients with this infectious spinal disease.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Sponsor | The Affiliated Hospital of Inner Mongolia Medical University (other) |
| Locations | 1 site (Hohhot, Inner Mongolia) |
| Trial ID | NCT06220500 on ClinicalTrials.gov |
What this trial studies
This observational study aims to improve the diagnosis of Brucella spondylitis, an infectious spinal disease, by utilizing advanced MRI techniques and radiomics analysis. The study will involve 100 patients diagnosed with Brucella spondylitis at the Affiliated Hospital of Inner Mongolia Medical University, where clinical data and MRI scans will be collected. The investigators will segment affected vertebral bodies and extract radiomics features to develop predictive models using machine learning techniques. The goal is to enhance diagnostic accuracy and provide better insights into the disease's pathophysiology.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18-70 who have been diagnosed with brucellosis and exhibit symptoms of brucella spondylitis.
Not a fit: Patients with serious comorbidities, a history of malignant tumors of the vertebral body, or contraindications to MRI may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more accurate and non-invasive diagnostic methods for Brucella spondylitis, improving patient outcomes.
How similar studies have performed: While the use of radiomics in MRI for diagnosing various conditions is gaining traction, this specific application for Brucella spondylitis is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Outpatients/Inpatients 2. Age 18-70 years 3. Meet diagnostic criteria for brucellosis 4. Meet symptoms of brucellosis spondylitis 5. Voluntarily sign an informed consent form 6. Can cooperate with MRI examination Exclusion Criteria: 1. Patients with serious diseases of other systems 2. History of malignant tumors of the vertebral body 3. History of tuberculosis 4. Contraindications to magnetic resonance imaging
Where this trial is running
Hohhot, Inner Mongolia
- Affiliated Hospital of Inner Mongolia Medical University — Hohhot, Inner Mongolia, China (RECRUITING)
Study contacts
- Study coordinator: Peng fei Qiao, MD
- Email: 24853170@qq.com
- Phone: 15904718239
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Brucella Spondylitis, Radiomics, MRI